242 related articles for article (PubMed ID: 12792754)
1. Influence of platelet-derived endothelial cell growth factor/thymidine phosphorylase on the cell cycle in head and neck squamous cell carcinoma in vitro.
Igawa H; Fujieda S; Kimura Y; Sugimoto C; Tanaka N; Ohtsubo T; Kato Y; Saito H
Oncol Rep; 2003; 10(4):967-71. PubMed ID: 12792754
[TBL] [Abstract][Full Text] [Related]
2. Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas.
Tsuzuki H; Sunaga H; Ito T; Narita N; Sugimoto C; Fujieda S
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1071-8. PubMed ID: 16365220
[TBL] [Abstract][Full Text] [Related]
3. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
[TBL] [Abstract][Full Text] [Related]
4. Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma.
Fujieda S; Sunaga H; Tsuzuki H; Tanaka N; Saito H
Clin Cancer Res; 1998 Jul; 4(7):1583-90. PubMed ID: 9676830
[TBL] [Abstract][Full Text] [Related]
5. Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase.
Miyadera K; Sumizawa T; Haraguchi M; Yoshida H; Konstanty W; Yamada Y; Akiyama S
Cancer Res; 1995 Apr; 55(8):1687-90. PubMed ID: 7536129
[TBL] [Abstract][Full Text] [Related]
6. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study.
Fox SB; Moghaddam A; Westwood M; Turley H; Bicknell R; Gatter KC; Harris AL
J Pathol; 1995 Jun; 176(2):183-90. PubMed ID: 7636628
[TBL] [Abstract][Full Text] [Related]
8. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
Wang MB; Yip HT; Srivatsan ES
Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer.
Toi M; Inada K; Hoshina S; Suzuki H; Kondo S; Tominaga T
Clin Cancer Res; 1995 Sep; 1(9):961-4. PubMed ID: 9816067
[TBL] [Abstract][Full Text] [Related]
10. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S
Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of p27KIP1 gene transfer on head and neck squamous cell carcinoma cell lines.
Koh TY; Park SW; Park KH; Lee SG; Seol JG; Lee DW; Lee CT; Heo DS; Kim KH; Sung MW
Head Neck; 2003 Jan; 25(1):44-9. PubMed ID: 12478543
[TBL] [Abstract][Full Text] [Related]
12. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers.
Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
Br J Cancer; 1999 Mar; 79(7-8):1249-54. PubMed ID: 10098767
[TBL] [Abstract][Full Text] [Related]
13. The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast.
Ellis PE; Wong Te Fong LF; Rolfe KJ; Crow JC; Reid WM; Davidson T; MacLean AB; Perret CW
Anticancer Res; 2002; 22(2A):857-61. PubMed ID: 12014662
[TBL] [Abstract][Full Text] [Related]
14. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease.
Saito S; Tsuno NH; Sunami E; Hori N; Kitayama J; Kazama S; Okaji Y; Kawai K; Kanazawa T; Watanabe T; Shibata Y; Nagawa H
J Gastroenterol; 2003; 38(3):229-37. PubMed ID: 12673445
[TBL] [Abstract][Full Text] [Related]
15. Effect of p27Kip1 on the ability of invasion and metastasis of an oral cancer cell line.
Supriatno ; Harada K; Kawaguchi S; Yoshida H; Sato M
Oncol Rep; 2003; 10(3):527-32. PubMed ID: 12684618
[TBL] [Abstract][Full Text] [Related]
16. Expression of basic fibroblast growth factor is associated with a good outcome in patients with squamous cell carcinoma of the esophagus.
Nakamura T; Ozawa S; Kitagawa Y; Shih CH; Ueda M; Kitajima M
Oncol Rep; 2005 Sep; 14(3):617-23. PubMed ID: 16077964
[TBL] [Abstract][Full Text] [Related]
17. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.
Liekens S; Bronckaers A; Pérez-Pérez MJ; Balzarini J
Biochem Pharmacol; 2007 Dec; 74(11):1555-67. PubMed ID: 17572389
[TBL] [Abstract][Full Text] [Related]
18. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
19. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas.
Taguchi T; Kato Y; Baba Y; Nishimura G; Tanigaki Y; Horiuchi C; Mochimatsu I; Tsukuda M
Oncol Rep; 2004 Feb; 11(2):421-6. PubMed ID: 14719078
[TBL] [Abstract][Full Text] [Related]
20. Interrelationship of platelet-derived endothelial cell growth factor, liver macrophages, and tumor microvessel density in patients with cholangiocellular carcinoma.
Miwa S; Soeda J; Miyagawa S
Hepatogastroenterology; 2005; 52(65):1398-402. PubMed ID: 16201082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
